BVF PARTNERS L P/IL
SEC CIK 1055947 · EDGAR
BoughtSold
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-26 18:48 | 2026-06-26 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | S - Sale | $106.50 | -1.58M | 240.1K | -87% | -$168.14M |
| I | 2026-06-26 18:48 | 2026-06-26 | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | S - Sale | $106.50 | -51.9K | 78.8K | -40% | -$5.52M |
| M | 2026-04-02 16:48 | 2026-03-31 | MLTX | MoonLake Immunotherapeutics | BVF PARTNERS L P/IL | Dir, 10% | S - Sale | $16.79 | -3.75M | 1.04M | -78% | -$62.96M |
| M | 2022-05-31 | 2022-05-26+ | KYMR | Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | P - Purchase | $14.34 | +289.4K | 1.60M | +22% | +$4.15M |
Purchase Sale Sale after option exercise All abbreviations